Intraductal Papillary Mucinous Tumor of the Native Pancreas in a Pancreas-Kidney Transplant Recipient

Tun Jie, James V. Harmon, H. Evin Gulbahce, Rainer Gruessner

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Recent data from the International Pancreas Transplant Registry confirm the benefits of pancreas transplantation, even in high-risk diabetic patients previously considered unqualified for such procedures. With patient survival currently extending into decades, de novo malignancies are now more frequently diagnosed in pancreas recipients. This is the first reported case of an intraductal papillary mucinous tumor of the native pancreas in a high-risk pancreas after kidney recipient. The patient underwent a partial pancreaticoduodenectomy and has remained tumor-free for 9 months. This case report demonstrates that (1) pancreas transplantation can be successfully done in patients with significant cardiocerebrovascular disease, (2) de novo pancreas malignancies can occur within the first year after pancreas transplantation, and (3) tumors of the native pancreas warrant the same surgical treatment in pancreas recipients as in the general population, despite the need for posttransplant immunosuppression and the increased operative risk.

Original languageEnglish (US)
Pages (from-to)446-449
Number of pages4
Issue number4
StatePublished - May 1 2004


  • Intraductal papillary mucinous tumor of the pancreas
  • Pancreas transplant


Dive into the research topics of 'Intraductal Papillary Mucinous Tumor of the Native Pancreas in a Pancreas-Kidney Transplant Recipient'. Together they form a unique fingerprint.

Cite this